Stergios Tzikas, Lars Palapies, Constantinos Bakogiannis, Tanja Zeller, Christoph Sinning, Stephan Baldus, Christoph Bickel, Vassilios Vassilikos, Karl Johannes Lackner, Andreas M. Zeiher, Thomas Münzel, Stefan Blankenberg, Till Keller
- Background: Treatment of patients presenting with possible acute myocardial infarction (AMI) is based on timely diagnosis and proper risk stratification aided by biomarkers. We aimed at evaluating the predictive value of GDF-15 in patients presenting with symptoms suggestive of AMI.
Methods: Consecutive patients presenting with suspected AMI were enrolled in three study centers. Cardiovascular events were assessed during a follow-up period of 6 months with a combined endpoint of death or MI.
Results: From the 1818 enrolled patients (m/f = 1208/610), 413 (22.7%) had an acute MI and 63 patients reached the combined endpoint. Patients with MI and patients with adverse outcome had higher GDF-15 levels compared with non-MI patients (967.1pg/mL vs. 692.2 pg/L, p<0.001) and with event-free patients (1660 pg/mL vs. 756.6 pg/L, p<0.001). GDF-15 levels were lower in patients with SYNTAX score ≤ 22 (797.3 pg/mL vs. 947.2 pg/L, p = 0.036). Increased GDF-15 levels on admission were associated with a hazard ratio of 2.1 for death or MI (95%CI: 1.67–2.65, p<0.001) in a model adjusted for age and sex and of 1.57 (1.13–2.19, p = 0.008) adjusted for the GRACE score variables. GDF-15 showed a relevant reclassification with regards to the GRACE score with an overall net reclassification index (NRI) of 12.5% and an integrated discrimination improvement (IDI) of 14.56% (p = 0.006).
Conclusion: GDF-15 is an independent predictor of future cardiovascular events in patients presenting with suspected MI. GDF-15 levels correlate with the severity of CAD and can identify and risk-stratify patients who need coronary revascularization.
MetadatenAuthor: | Stergios TzikasORCiDGND, Lars Palapies, Constantinos Bakogiannis, Tanja ZellerORCiDGND, Christoph SinningGND, Stephan BaldusGND, Christoph Bickel, Vassilios Vassilikos, Karl Johannes LacknerORCiD, Andreas M. ZeiherORCiDGND, Thomas MünzelORCiDGND, Stefan BlankenbergORCiDGND, Till KellerORCiDGND |
---|
URN: | urn:nbn:de:hebis:30:3-439769 |
---|
DOI: | https://doi.org/10.1371/journal.pone.0182314 |
---|
ISSN: | 1932-6203 |
---|
Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/28771550 |
---|
Parent Title (English): | PLoS one |
---|
Publisher: | PLoS |
---|
Place of publication: | Lawrence, Kan. |
---|
Contributor(s): | Andreas Zirlik |
---|
Document Type: | Article |
---|
Language: | English |
---|
Date of Publication (online): | 2017/08/10 |
---|
Date of first Publication: | 2017/08/03 |
---|
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Release Date: | 2017/08/10 |
---|
Volume: | 12 |
---|
Issue: | (8): e0182314 |
---|
Page Number: | 13 |
---|
First Page: | 1 |
---|
Last Page: | 13 |
---|
Note: | Copyright: © 2017 Tzikas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
---|
HeBIS-PPN: | 416310478 |
---|
Institutes: | Medizin / Medizin |
---|
| Exzellenzcluster / Exzellenzcluster Herz-Lungen-System |
---|
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Licence (German): | Creative Commons - Namensnennung 4.0 |
---|